VectorXcellerator Programme: Fully funded feasibility studies to support early-stage cell and gene therapy programmes

Webinar: Optimising viral vector manufacturing with CDMO expertise and innovation

News: OXB honoured at 2025 CDMO Leadership Awards Europe in ‘Cell & Gene Therapy’ category

Engineering an AAV Viral Vector Production Cell Line SV40 T Antigen Locus Removal in HEK293T via Mad7 Genome Editing

October 23, 2024